SCHEMBL22157013

SCHEMBL22157013

Cc1ccc(-c2ccc3c4ccccc4n(-c4cc(-c5c(F)cccc5F)cc(-n5c6ccccc6c6ccc(-c7ccc(C)cc7C)cc65)c4C#N)c3c2)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 3/20 0.39
PDE1C Q14123 3/20 0.37
ALDH1A1 P00352 4/20 0.34
MAPT P10636 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 3/20 0.33
TP53 P04637 1/20 0.33
HIF1A Q16665 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTT P42858 2/20 0.32
TSHR P16473 1/20 0.32
HPGD P15428 4/20 0.31
GAA P10253 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
KDM4E B2RXH2 2/20 0.31
TDP1 Q9NUW8 1/20 0.31
PIK3R2 O00459 1/20 0.31
CYP2C9 P11712 2/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22157012 0.96 PDE9A (0.38) PDE9APDE1CALDH1A1MAPTMEN1
SCHEMBL22157014 0.94 PDE9A (0.39) PDE9APDE1CALDH1A1MAPTMEN1
SCHEMBL22158430 0.91 PDE9A (0.38) PDE9APDE1CALDH1A1MAPTMEN1
SCHEMBL22156497 0.91 AR (0.37) PDE9APDE1CALDH1A1MAPTMEN1
SCHEMBL22156486 0.90 PDE9A (0.41) PDE9APDE1CALDH1A1MAPTMEN1
SCHEMBL22158407 0.90 PDE9A (0.40) PDE9APDE1CALDH1A1MAPTMEN1
SCHEMBL22158424 0.89 PDE9A (0.37) PDE9APDE1CALDH1A1MAPTMEN1
SCHEMBL22156607 0.88 PDE9A (0.37) PDE9APDE1CALDH1A1MAPTMEN1
SCHEMBL22158395 0.88 PDE9A (0.34) PDE9APDE1CLMNATP53HIF1A
SCHEMBL22156492 0.88 PDE9A (0.38) PDE9APDE1CALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3635070-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-04-28 EP disclosed
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 PDE9A 4546/4885PDE1C 4637/4885ALDH1A1 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.